Estrogen Receptor-Positive Breast Carcinoma

Estrogen Receptor-Positive Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–11 of 11 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07391774	Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial	recruiting	Phase 3	1,978	National Cancer Institute (NCI)NIH	2	Sep 28, 2026	clinicaltrials
NCT06671912	Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial(LoTam)	suspended	Phase 3	1,556	Alliance for Clinical Trials in OncologyOTHER